| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 65 |
| 1 | QUETIAPINE | 59 |
| 2 | OLANZAPINE | 52 |
| 3 | RISPERIDONE | 50 |
| 4 | LORAZEPAM | 43 |
| 5 | ARIPIPRAZOLE ORAL | 36 |
| 6 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 36 |
| 7 | CITALOPRAM | 29 |
| 8 | METHYLPHENIDATE HYDROCHLORIDE | 29 |
| 9 | CITALOPRAM HYDROBROMIDE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZGALANTAMINE | 1 | 0.0122 |
| 1 | ACAMPROSATE CALCIUM | 2 | 0.0060 |
| 2 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 3 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 4 | L DOPA | 1 | 0.0037 |
| 5 | TRIENTINE TETRAHYDROCHLORIDE | 1 | 0.0033 |
| 6 | L-GLUTAMINE | 1 | 0.0028 |
| 7 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 8 | CHLORPROMAZINE HYDROCHLORIDE | 2 | 0.0021 |
| 9 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 1 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 178 |
| 1 | Benzodiazepine [EPC] | 80 |
| 2 | Mood Stabilizer [EPC] | 26 |
| 3 | Nonergot Dopamine Agonist [EPC] | 24 |
| 4 | Anti-epileptic Agent [EPC] | 23 |
| 5 | Proton Pump Inhibitor [EPC] | 23 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 23 |
| 7 | Typical Antipsychotic [EPC] | 22 |
| 8 | Aromatic Amino Acid [EPC] | 19 |
| 9 | Osmotic Laxative [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 12 | 0.0015 |
| 1 | Nonergot Dopamine Agonist [EPC] | 24 | 0.0015 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 7 | 0.0014 |
| 3 | Typical Antipsychotic [EPC] | 22 | 0.0009 |
| 4 | Influenza A M2 Protein Inhibitor [EPC] | 11 | 0.0007 |
| 5 | Monoamine Oxidase Inhibitor [EPC] | 2 | 0.0006 |
| 6 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 4 | 0.0005 |
| 8 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 9 | Atypical Antipsychotic [EPC] | 178 | 0.0004 |